InVivo Therapeutics Holdings Corp (NVIVQ)

[BesaoT35]

Once nerve growth factors and stem cells get used with the neuro-spinal scaffold NSS it could and hopefully will result in a dramatic improvement in nerve growth or axon growth outcomes.

Something like that could have broader uses in other neurodegenerative diseases, stroke or various psychiatric diseases perhaps.

The current Inspire 2.0 is only using the scaffold I think (correct me if I am wrong) that gets implanted into the spine. It alone shows improved spinal function scores and clinical outcomes.

I do not know of any direct competitors. Again please correct me if I am wrong about competition. I would expect a rising interest by investors and larger biotech companies in NVIV if clinical outcomes stay positive or become more positive.

Early investors have lost more than 99% of their early invested capital in NVIV so far, talking long term. It is the most negative performance , or one of the worst, that can be found for any stock long term that is not yet delisted.

Could this long decline reverse itself?